ClinConnect ClinConnect Logo
Search / Trial NCT05924178

Effects of Preoperative Rehabilitation on Tendon Healing, Bone Mineral Density, and Cartilage After ACLR and Patellar Dislocation

Launched by PEKING UNIVERSITY THIRD HOSPITAL · Jun 27, 2023

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how exercise before surgery can help patients who have torn their anterior cruciate ligament (ACL) heal better and improve bone health. The study aims to find out if preoperative rehabilitation—essentially, doing specific exercises before surgery—can positively affect things like tendon healing, bone density, and even how well patients walk after their surgery.

To be part of this trial, participants need to be between 18 and 40 years old, diagnosed with an ACL tear through an MRI, and should be planning to have their first surgery for this injury. They should also be at least six weeks post-injury but no more than six months from the time they got hurt. The trial is not yet recruiting participants, but if you meet the criteria and decide to join, you can expect to take part in exercises aimed at preparing you for surgery, which might help improve your recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age 18\~40 years old, diagnosed ACL rupture or Patellar Dislocation by MRI;
  • 2. The first unilateral ligamenta reconstruction at our hospital;
  • Exclusion Criteria:
  • 1. Be older than 40 years, or less than 18 years old
  • 2. Severe injury to other knee ligaments
  • 3. History of knee trauma

About Peking University Third Hospital

Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported